Based on these regulatory activities and the well-recognized pharmacological properties of mushrooms, in the present study, we hypothesized that fairy chemicals promote anticancer activity by decreasing the expression of Axl and immune checkpoint molecules in cancer cells. The gene discussed is AXL; the disease is cancer.